Literature DB >> 4091578

Why does congenital heart disease cause failure to thrive?

G Menon, E M Poskitt.   

Abstract

Metabolisable energy intake, determined by bomb calorimetry of food, vomit, stool and urine, and resting metabolism, assessed by respiratory gas exchange, were studied in 21 infants with congenital heart disease and nine control infants. Weight for age, growth rates, and daily metabolisable energy intake per kg tended to be lower in infants with heart disease than in control infants. Resting oxygen consumption was high in those infants with pulmonary hypertension and persistent cardiac failure. Energy intake, as a percentage of that recommended for age, correlated with weight gain, and resting oxygen consumption correlated inversely with both percentage body mass index and relative fatness. Failure to thrive in infants with congenital heart disease may be due to a combination of low energy intakes and, in some cases, high energy requirements allowing insufficient energy for normal growth. Increasing the energy intakes of infants with congenital heart disease may be a way of improving their growth.

Entities:  

Mesh:

Year:  1985        PMID: 4091578      PMCID: PMC1777687          DOI: 10.1136/adc.60.12.1134

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  Metabolic rate of neonates with congenital heart disease.

Authors:  A N Krauss; P A Auld
Journal:  Arch Dis Child       Date:  1975-07       Impact factor: 3.791

2.  A ballistic bomb calorimeter.

Authors:  D S MILLER; P R PAYNE
Journal:  Br J Nutr       Date:  1959       Impact factor: 3.718

3.  Growth disturbance in congenital heart disease.

Authors:  A MEHRIZI; A DRASH
Journal:  J Pediatr       Date:  1962-09       Impact factor: 4.406

4.  Growth of children with congenital heart disease.

Authors:  R H Feldt; G B Strickler; W H Weidman
Journal:  Am J Dis Child       Date:  1969-05

5.  Oxygen consumption in infants with heart disease. Relationship to severity of congestive failure, relative weight, and caloric intake.

Authors:  F P Stocker; W Wilkoff; O S Miettinen; A S Nadas
Journal:  J Pediatr       Date:  1972-01       Impact factor: 4.406

6.  Growth failure and congenital heart disease. Energy and nitrogen balance in infants.

Authors:  I Krieger
Journal:  Am J Dis Child       Date:  1970-12

7.  Energy retention, energy expenditure, and growth in healthy immature infants.

Authors:  O G Brooke; J Alvear; M Arnold
Journal:  Pediatr Res       Date:  1979-04       Impact factor: 3.756

8.  A method for assessing age-standardized weight-for-height in children seen cross-sectionally.

Authors:  T J Cole
Journal:  Ann Hum Biol       Date:  1979 May-Jun       Impact factor: 1.533

9.  Body fat assessed from total body density and its estimation from skinfold thickness: measurements on 481 men and women aged from 16 to 72 years.

Authors:  J V Durnin; J Womersley
Journal:  Br J Nutr       Date:  1974-07       Impact factor: 3.718

10.  Intestinal function in infants with severe congenital heart disease.

Authors:  J M Sondheimer; J R Hamilton
Journal:  J Pediatr       Date:  1978-04       Impact factor: 4.406

View more
  26 in total

1.  Genetic factors are important determinants of impaired growth after infant cardiac surgery.

Authors:  Nancy Burnham; Richard F Ittenbach; Virginia A Stallings; Marsha Gerdes; Elaine Zackai; Judy Bernbaum; Robert R Clancy; J William Gaynor
Journal:  J Thorac Cardiovasc Surg       Date:  2010-04-09       Impact factor: 5.209

2.  Somatic growth following congenital heart surgery in economically underprivileged children.

Authors:  Pankajkumar A Kasar; Raghavan Nair Suresh Kumar; Vellappillil Raman Kutty
Journal:  Heart Asia       Date:  2011-01-01

Review 3.  Report of the National Heart, Lung, and Blood Institute's Working Group on obesity and other cardiovascular risk factors in congenital heart disease.

Authors:  Victoria L Pemberton; Brian W McCrindle; Shari Barkin; Stephen R Daniels; Sarah E Barlow; Helen J Binns; Meryl S Cohen; Christina Economos; Myles S Faith; Samuel S Gidding; Caren S Goldberg; Rae-Ellen Kavey; Patricia Longmuir; Albert P Rocchini; Linda Van Horn; Jonathan R Kaltman
Journal:  Circulation       Date:  2010-03-09       Impact factor: 29.690

4.  Failure to thrive in congenital heart disease.

Authors:  E M Poskitt
Journal:  Arch Dis Child       Date:  1993-02       Impact factor: 3.791

5.  Passive range of motion exercise to enhance growth in infants following the Norwood procedure: a safety and feasibility trial.

Authors:  Linda M Lambert; Felicia L Trachtenberg; Victoria L Pemberton; Janine Wood; Shelley Andreas; Robin Schlosser; Teresa Barnard; Kaitlyn Daniels; Ann T Harrington; Nicholas Dagincourt; Thomas A Miller
Journal:  Cardiol Young       Date:  2017-03-23       Impact factor: 1.093

6.  Site of interstage outpatient care and growth after the Norwood operation.

Authors:  Mehul D Patel; Karen Uzark; Sunkyung Yu; Janet Donohue; Sara K Pasquali; David Schidlow; David W Brown; Sarah Gelehrter
Journal:  Cardiol Young       Date:  2015-01-02       Impact factor: 1.093

7.  The Effect on Somatic Growth of Surgical and Catheter Treatment of Secundum Atrial Septal Defects.

Authors:  Meghan M Chlebowski; Hongying Dai; Stephen F Kaine
Journal:  Pediatr Cardiol       Date:  2017-07-18       Impact factor: 1.655

8.  Long term somatic growth after repair of tetralogy of Fallot: evidence for restoration of genetic growth potential.

Authors:  M M H Cheung; A M Davis; J L Wilkinson; R G Weintraub
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

9.  Decreased serum insulin-like growth factor-I associated with growth failure in newborn lambs with experimental cyanotic heart disease.

Authors:  D Bernstein; J R Jasper; R G Rosenfeld; R L Hintz
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

10.  Mechanism of decreased forward stroke volume in children and swine with ventricular septal defect and failure to thrive.

Authors:  W J Corin; M M Swindle; J F Spann; K Nakano; M Frankis; R W Biederman; A Smith; A Taylor; B A Carabello
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.